Dexcel Pharma Ltd expands portfolio in the UK and Ireland

Dexcel Pharma Ltd, part of the privately owned pharmaceutical company Dexcel Pharma Group which develops, manufactures, and commercialises products internationally, has expanded its OTC portfolio in the UK and Ireland. The company has acquired eight new consumer healthcare brands across the therapeutic areas gastro, sleep, male health, ear health, skin care and supplements.

EarCalm Spray, night time sleep aid Sominex, antacid Wind-Eze, Bisodol Indigestion Relief Tablets, cold sore treatment Cymex, erectile dysfunction treatment Liberize, Yeast Vite supplements and catarrh and head cold remedy MacKenzies Smelling Salts have all been acquired by Dexcel Pharma Ltd.

“We are delighted to welcome these established brands to our growing consumer healthcare portfolio which is built on our drive for innovation and the opportunity to answer patient needs,” said Andrew Ridsdale, managing director of Dexcel Pharma Ltd. “There is strong brand awareness around these products which are trusted among consumers and healthcare professionals alike. They offer us exciting avenues for both scale and growth within the UK and Ireland."